NCT00206492View on ClinicalTrials.gov

Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients

PHASE2TerminatedINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions

Breast Cancer

Interventions

DRUG

Iressa

Iressa

DRUG

Tamoxifen

Tamoxifen

Trial Locations (1)

77030

Baylor Breast Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Baylor Breast Care Center

OTHER